September 10, 2026
Agency
What Happens When a Medical Device Gets Recalled — And How Insurance Factors In
By the time the FDA calls, it’s already too late to figure out whether your policy actually covers a recall. Here’s what to understand before that call comes.
For most medtech companies, a recall exists only as an abstract risk — something that happens to other manufacturers, in other product categories, after other people’s mistakes. The reality is less rare than that framing suggests, and the financial mechanics of a recall catch even well-prepared companies off guard, because the insurance most device makers carry was never actually built to absorb one.
Here’s what actually happens when a device gets recalled, and where the coverage gap tends to sit.
Voluntary vs. Mandatory: A Distinction That Changes Everything
Nearly all medical device recalls are voluntary. From fiscal years 2020 to 2024, the FDA oversaw the recall of thousands of medical devices — and every single one was voluntarily initiated by the manufacturer. The FDA does hold mandatory recall authority under Section 518(e) of the Federal Food, Drug, and Cosmetic Act, but it’s used only in rare cases, reserved for situations where a manufacturer refuses to act on a device presenting a serious health risk.
The word “voluntary” is doing a lot of work in that sentence, though, and it’s worth understanding what it actually means in practice. A voluntary recall isn’t the manufacturer’s idea in any meaningful sense — it’s initiated because the alternative is FDA enforcement action, and companies that delay or resist have seen that hesitation escalate quickly toward seizures, injunctions, or a mandatory order. In 2026’s regulatory environment, FDA has expanded early-alert communications and increased public visibility around device recalls before companies are always fully prepared, making “voluntary” recalls feel considerably less optional than the label suggests.
For insurance purposes, this distinction matters because policy language sometimes draws a line between recalls a company initiates and those an agency orders. The good news: recall insurance, where a company has it, typically covers both voluntary and involuntary recalls. The catch is in that qualifier — “where a company has it” — because recall coverage is far from standard.
Recall Expense Coverage: The Policy Most Companies Assume They Have and Don’t
This is the single most important thing for medtech leadership to understand: a standard product liability policy responds to third-party claims — a patient or provider alleging your device caused harm. It does not pay for the operational cost of the recall itself.
Recall expense coverage is a distinct policy, or a specific endorsement added to an existing one, and it’s frequently absent from a device company’s insurance program entirely. Companies often discover this gap only once a recall is already underway — precisely the moment it’s most expensive to learn.
The reason this gap is so common isn’t negligence. It’s that product liability and recall expense address two entirely different financial events. One responds to “a patient was harmed and is suing you.” The other responds to “you need to physically retrieve, replace, or correct thousands of units in the field, right now.” A company can carry excellent coverage for the first scenario and none at all for the second.
The True Cost of a Recall
Recall expense adds up across several categories that rarely make it into a company’s initial risk planning:
Customer and provider notification. Identifying every account, distributor, and clinical site that received the affected device, then formally notifying each one — a process that has to be documented meticulously for FDA reporting requirements.
Unit retrieval. Physically recovering devices already in the field, from hospital storage rooms to individual clinician offices, often across a wide geographic footprint.
Replacement or correction. Manufacturing and shipping replacement units, or dispatching field teams to correct devices in place, depending on the nature of the defect.
Regulatory response. Legal and regulatory counsel, FDA correspondence, corrective action documentation, and the internal resources required to manage an active FDA inquiry alongside normal operations.
Reputational damage. The hardest cost to quantify and often the most lasting — lost trust with hospital systems, delayed sales cycles for unrelated products in your portfolio, and the internal cost of managing the narrative with investors, partners, and clinical advisory boards.
None of these costs are covered by a standard product liability policy. All of them are real, immediate, and often due well before any third-party claim from an injured patient even reaches litigation.
How a Recall Claim Actually Gets Processed — And Where Policies Fall Short
Step 1: Internal identification. A quality or post-market surveillance signal — an adverse event report, a complaint pattern, an internal audit finding — triggers an internal investigation into whether a device correction or removal is warranted.
Step 2: The recall decision and FDA notification. If the company proceeds, it has 10 working days to report the correction or removal to the FDA under 21 CFR Part 806, assuming the action was taken to reduce a risk to health. The FDA reviews, classifies the recall by severity, and monitors the process — but does not typically manage the operational execution itself.
Step 3: Insurance notification. This is where policy gaps become visible fastest. If the company’s only coverage is standard product liability, the insurer’s involvement may not begin meaningfully until a third-party claim is actually filed — leaving the company to fund notification, retrieval, and replacement entirely out of pocket in the interim, sometimes for months.
Step 4: Claim processing under a recall expense policy, if one exists. Where recall expense coverage is in place, the process runs in parallel to the FDA process: documented recall costs are submitted to the insurer, typically requiring detailed records of notification efforts, retrieval logistics, and replacement costs, often audited closely given the size of typical claims.
Where policies commonly fall short: even companies that do carry recall coverage frequently find their limits calibrated to an earlier, smaller stage of the business — a policy sized for a startup with a few hundred units in the field, still in place once the company has tens of thousands of units across a national distribution network. Sublimits on notification costs, retrieval logistics, or crisis communications can also be set well below what an actual recall at scale requires.
Building Recall Preparedness Into Your Risk Framework Before the Call Comes
Confirm whether you have recall expense coverage at all. If your current policy is limited to product liability, ask your broker directly whether recall expense is included, excluded, or available as an add-on. Don’t assume it’s bundled in.
Size your coverage to your actual installed base, not your funding stage. As your device reaches more clinical sites and more patients, your potential recall exposure grows in direct proportion. Review your recall coverage limits at the same cadence you review your product liability limits — tied to commercial milestones, not renewal dates.
Build a recall response plan before you need one. Insurance responds faster and more completely when a company can demonstrate an organized, documented recall process — traceability of units, a notification protocol, and a clear internal chain of responsibility. This isn’t just operationally sound; it directly affects how smoothly a recall claim gets processed.
Understand your policy’s definition of a covered recall event. Some policies are triggered only by regulatory action; others extend to any recall a company reasonably determines is necessary to prevent harm. Given how much recall activity in 2026 is technically voluntary but effectively mandatory, this distinction is worth clarifying with your broker directly, in writing, before a recall is underway.
The Bottom Line
The recall itself is rarely the surprise — quality and regulatory teams generally know the risk exists. The surprise is discovering, mid-recall, that the policy in place was never built to fund the actual mechanics of pulling a device out of the field. Confirming recall expense coverage, sizing it to your real installed base, and having a documented response plan in place are the difference between a recall that strains the business and one that ends it.
This article is for educational purposes only and does not constitute legal or insurance advice. Consult any of our licensed insurance professionals with life sciences expertise to review your specific coverage needs.